clinical trial · NCT05643729
Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)
COPDZofinPlacebo
brief summary
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of Zofin for the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
started
Nov 15, 2023
primary completion
May 30, 2024
completion
Aug 31, 2024
last updated
Nov 1, 2023
detailed description
Total of 20 adult patients will be chosen from population of adults between the age of 40 to 80 diagnosed with COPD to be randomized to 1 of 2 treatment arms including IV infusion of Zofin or IV infusion on sterile saline.
The subjects will be followed for 12 months to demonstrate safety and efficacy of Zofin.
official title
A Phase I/II Randomized, Double Blinded, Placebo Trial to Evaluate the Safety and Potential Efficacy of Intravenous Infusion (IV) of ZofinTM for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol